Top Markets
#1 Nesa Nesa +803.49%
#2 Cortex Cortex +68.67%
#3 Kinesis Silver Kinesis Silver +55.82%
#4 Merlin's Seal BTC Merlin's Seal BTC +45.67%
#5 QuantixAI QuantixAI +24.00%
#6 EXOD EXOD +22.78%
#7 Cash Cat Cash Cat +22.43%
#8 Alchemist AI Alchemist AI +17.55%
#9 Pons Pons +16.98%
#10 Instadapp Instadapp +16.15%
Coin of the day
Nesa Nesa
Settings
Language
ENGLISH
Currency
USD
Theme
Columbia Care Inc. Columbia Care Inc.

Columbia Care Inc.

CCHW
Rank in Stocks #19273
Columbia Care Inc. is a company operating in the cannabis sector, engaged in... Columbia Care Inc. is a company operating in the cannabis sector, engaged in the cultivation, manufacturing, and distribution of a broad array of cannabis products and associated services. The firm's product lineup includes diverse forms such as flowers, edibles, oils, and tablets, marketed under its various proprietary brands, including Seed & Strain, Triple Seven, gLeaf, Classix, Press, Amber, and Platinum Label CBD. The company holds essential licenses to conduct its operations across 18 distinct jurisdictions, encompassing territories within both the United States and the European Union. As of mid-June 2022, Columbia Care maintained an extensive operational footprint comprising 131 facilities; specifically, this included 99 retail dispensaries and 32 sites dedicated to cultivation and manufacturing processes. Columbia Care was established in 2012 and its corporate headquarters are situated in New York, New York.
Share Price
$0.41100466
Last synced: 2023-08-02
Market Cap
$167.82M
Change (1 day)
-0.82%
Change (1 year)
0.00%
Country
US
Trade Columbia Care Inc. (CCHW)

Category

Healthcare
P/E ratio for Columbia Care Inc. (CCHW)
P/E ratio as of 2026 TTM: 0
According to Columbia Care Inc. latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is 0. At the end of 2026 the company had a P/E ratio of 0.
P/E ratio history for Columbia Care Inc. from 2026 to 2026
P/E ratio at the end of each year
Year P/E Ratio Change
Not enough data for the provided dates.
P/E ratio for similar companies or competitors
Company P/E Ratio P/E Ratio Difference Country
MERCK Kommanditgesellschaft auf Aktien MERCK Kommanditgesellschaft auf Aktien
MERCK Kommanditgesellschaft auf Aktien
MER.SW
 - -
DE
Merck KGaA Merck KGaA
Merck KGaA
MRK.DE
 - -
DE
Takeda Pharmaceutical Company Limited Takeda Pharmaceutical Company Limited
Takeda Pharmaceutical Company Limited
4502.T
 - -
JP
Galderma Group AG Galderma Group AG
Galderma Group AG
GALD.SW
 - -
CH
Sun Pharmaceutical Industries Limited Sun Pharmaceutical Industries Limited
Sun Pharmaceutical Industries Limited
SUNPHARMA.NS
 38.29 -
IN
How to read a P/E ratio?

The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share.
A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.

Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.

Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.